Today: 21 January 2026
Subscribe
Browse Category

NASDAQ:CRVS News 21 January 2026

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

Corvus Pharmaceuticals stock whipsaws: CRVS slides after $150 million offering follows eczema data surge

New York, January 21, 2026, 05:35 ET — Premarket Shares of Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS) dropped nearly 8%, slipping to $19.68 in premarket trading Wednesday. The decline follows the company’s announcement of an underwritten public offering worth $150 million in common stock and pre-funded warrants. These warrants let investors lock in shares now by paying most of the price…
21 January 2026
·····
Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

New York, Jan 20, 2026, 19:13 ET — After-hours Corvus Pharmaceuticals shares surged over threefold on Tuesday following fresh data release on its experimental eczema pill. The biotech also announced plans to raise $150 million through an underwritten stock offering. After-hours trading saw the stock surge roughly 167% to $21.41, with about 84 million shares changing hands. This move matters…
21 January 2026
·····

Stock Market Today

  • AB Volvo Share Price Pullback Highlights Potential Undervaluation Amid Cooling Momentum
    January 21, 2026, 9:01 AM EST. AB Volvo's (OM:VOLV B) share price has cooled slightly, falling 0.5% in the past day and 0.8% over the week, despite a solid 18.92% gain over 90 days. Trading at SEK 304.9, the stock's price-to-earnings (P/E) ratio stands at 17.4x, notably below the Swedish Machinery industry average of 25x and peers at 36.3x, suggesting potential undervaluation. The discounted cash flow (DCF) model estimates fair value at SEK 482.69, implying a 36.8% upside. However, caution is advised due to risks including softer demand for trucks and construction equipment that could pressure margins. Investors face the question of whether current market prices already factor in future growth or if hidden value remains in AB Volvo shares.
Go toTop